Ten Pharma Companies in India
Namaste India,
Medicine and healthcare are an ever-growing industry across the globe. Technology and innovation drive this industry forward and our country has seen tremendous growth in the pharma sector. Today we will showcase the top 10 pharma companies in India which has changed the healthcare industry in a good way.
Top 10 pharma company
1. Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd is one of the top 10 pharma companies in India and it is an Indian multinational pharmaceutical company. The company manufactures and sells pharmaceutical formulations as well as active pharmaceutical ingredients (APIs) in India as well as the U.S. The company has its headquarters in Mumbai, Maharastra.
Formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology, and diabetology is the main functional areas of this company. It also provides APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anti-cancers, steroids, peptides, sex hormones, and controlled substances.
Market Cap: 94,378 Cr.
ROE: 9.19 %
Sales Growth (3Yrs): 0.67 %
Promoter holding: 54.56 %
Debt to equity: 0.25
Price to book value: 2.28
2. Aurobindo Pharma Ltd
Aurobindo Pharma was founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy, and a small group of highly committed professionals. They created this company with an elite vision of serving healthcare needs. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.
Market Cap: 27,615 Cr.
ROE: 19.01 %
Sales Growth (3Yrs): 12.41 %
Promoter holding: 51.87 %
Debt to equity: 0.37
Price to book value: 1.82
3. Cipla
One of the most famous and trusted pharma companies in India is Cipla which is also a leading global pharmaceutical company, dedicated to high-quality, branded, and generic medicines. The Company is trusted by healthcare professionals and patients across geographies. The company has strengthened its global focus by consolidating and deepening its presence in the key markets of India, South Africa, the US, and other economies of the emerging world. The company has its headquarter situated in Mumbai, India.
Market Cap: 29,497 Cr.
ROE: 5.38 %
Sales Growth (3Yrs): 5.46 %
Promoter holding: 46.93 %
Debt to equity: 0.64
Price to book value: 2.17
4. Dr. Reddy’s Laboratories Ltd
Dr. Reddy’s Laboratories Ltd is also a trusted pharma brand among Indian citizens and it has a 17.00 % Stock Weighatage in the Nifty Pharma Index. The company is the fifth-largest in the list of top ten pharma companies in India.
Market Cap: 50,867 Cr.
ROE: 13.61 %
Sales Growth (3Yrs): -0.26 %
Promoter holding: 26.76 %
Debt to equity: 0.17
Price to book value: 3.30
The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.
Top Ten Most Spoken Indian Language
5. Cadila Healthcare Ltd
Zydus Cadila is headquartered in Ahmedabad, India, and ranks 4th in the Indian pharmaceutical industry. The group has manufacturing sites and research facilities spread across five states of Gujarat, Maharashtra, Goa, Himachal Pradesh and Sikkim in India and in the US and Brazil.
Market Cap: 26,228 Cr.
ROE: 18.66 %
Sales Growth (3Yrs): 11.78 %
Promoter holding: 74.88 %
Debt to equity: 0.69
Price to book value: 2.55
6. Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals is a global pharmaceutical company. The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). It has 17 manufacturing facilities and 5 R&D centers dedicated to the goal of enriching lives across the globe. The Company is among the Top list of pharmaceutical companies in India
Market Cap: 7,505 Cr.
ROE: 15.20 %
Sales Growth (3Yrs): 9.27 %
Promoter holding: 46.59 %
Debt to equity: 0.60
Price to book value: 1.27
7. Torrent Pharmaceuticals Ltd
Torrent Pharma belongs to the flagship Company of Torrent Group and is one of the leading pharma companies in the Country.Torrent Pharma’s active areas in the pharma industry include therapeutic areas of Cardiovascular (CV), central nervous system (CNS), gastrointestinal, diabetology, anti-infective, and pain management segments.
Market Cap: 35,530 Cr.
ROE: 12.75 %
Sales Growth (3Yrs): 4.69 %
Promoter holding: 71.25 %
Debt to equity: 0.85
Price to book value: 7.00
8. Alkem Laboratories Ltd
Established in 1973, high-quality branded generics, generic drugs, active pharmaceutical ingredients, and nutraceuticals, which the company markets in India and over 50 countries internationally.
With a comprehensive portfolio of over 750 brands covering all the major therapeutic segments and a robust pan-India sales and distribution network, The company is ranked amongst the top ten pharmaceutical companies in India in terms of domestic sales for the past 15 years.
Market Cap: 30,691 Cr.
ROE: 14.84 %
Sales Growth (3Yrs): 14.47 %
Promoter holding: 66.04 %
Debt to equity: 0.24
Price to book value: 5.22
9. Divi’s Laboratories Ltd
Headquartered in Hyderabad, Divis Laboratories is engaged in the manufacture of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceutical ingredients with predominance in exports. The company has a total net sales of Rs 4880 Crs.
Market Cap: 57,919 Cr.
ROE: 21.01 %
Sales Growth (3Yrs): 9.41 %
Promoter holding: 52.00 %
Debt to equity: 0.00
Price to book value: 8.18
Divi’s has been established for more than 29 years in Hyderabad, India with two manufacturing units and is among the top pharmaceutical companies in India.
10. Lupin
Lupin is a global pharmaceutical company offering a wide range of products such as Branded & Generic Formulations, Biotechnology Products, Active Pharmaceutical Ingredients (APIs), and Specialty. The company has total sales of Rs 16718 Crs. Lupin’s world-class manufacturing facilities are spread across India, Japan, the USA, Mexico, and Brazil. Based out of Mumbai, India, the company aims to provide healthcare and medicines at an affordable rate for all Indians.
Market Cap: 29,497 Cr.
ROE: 5.38 %
Sales Growth (3Yrs): 5.46 %
Promoter holding: 46.93 %
Debt to equity: 0.64
Price to book value: 2.17
Thanks for reading this out.Hope you enjoy this article.
Follow us for more informative articles like this.